title: Effects of repeated intravitreal bevacizumab injections on the inner retinal function in neovascular age-related macular degeneration.
authors.forename: Hoon Dong
authors.initials: HD
authors.lastname: Kim
authors.forename: Seung Hoon
authors.initials: SH
authors.lastname: Kim
authors.forename: In Hwan
authors.initials: IH
authors.lastname: Cho
authors.forename: Chan Hee
authors.initials: CH
authors.lastname: Moon
authors.forename: Young-Hoon
authors.initials: YH
authors.lastname: Ohn
authors.forename: Tae Kwann
authors.initials: TK
authors.lastname: Park
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D004596:Electroretinography / Q000187:drug effects*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D051245:Retinal Bipolar Cells / Q000502:physiology*; D012165:Retinal Ganglion Cells / Q000502:physiology*; D019233:Retreatment; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology; D057135:Wet Macular Degeneration / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab